Home › Kidney Cancer
Kidney Cancer clinical trials recruiting in the U.S.
59 studies for Kidney Cancer are recruiting participants at sites across the United States.
Kidney cancer symptoms are hard to detect at first but they do exist. Read more about the top 5 symptoms and the treatment options available
Cities with the most studies
- New York City, NY15 studies
- Boston, MA12 studies
- Nashville, TN12 studies
- Houston, TX10 studies
- Washington, DC9 studies
- San Diego, CA9 studies
- St. Louis, MO9 studies
- Dallas, TX9 studies
- Seattle, WA8 studies
- Edison, NJ8 studies
- Baltimore, MD7 studies
- Miami, FL7 studies
- Los Angeles, CA7 studies
- Rochester, MN7 studies
- Jacksonville, FL7 studies
- Durham, NC6 studies
- Aurora, CO6 studies
- Mountain View, CA6 studies
- Omaha, NE6 studies
- Baldwin Park, CA6 studies
- Queens, NY6 studies
- Cleveland, OH5 studies
- Phoenix, AZ5 studies
- Pittsburgh, PA5 studies
- Columbus, OH5 studies
- New Rochelle, NY5 studies
- Staten Island, NY5 studies
- Louisville, KY4 studies
- Portland, OR4 studies
- New Haven, CT4 studies
- Atlanta, GA4 studies
- Highlands Ranch, CO4 studies
- Detroit, MI4 studies
- San Francisco, CA4 studies
- Denver, CO4 studies
- Orange, CA4 studies
- East Norwalk, CT4 studies
- San Antonio, TX4 studies
- Gilbert, AZ3 studies
- Waukegan, IL3 studies
By state
- Arizona8 studies
- Arkansas3 studies
- California19 studies
- Colorado9 studies
- Connecticut6 studies
- Florida14 studies
- Georgia6 studies
- Illinois7 studies
- Indiana4 studies
- Iowa4 studies
- Kentucky4 studies
- Louisiana3 studies
- Maryland16 studies
- Massachusetts14 studies
- Michigan6 studies
- Minnesota10 studies
- Missouri10 studies
- Nebraska6 studies
- New Jersey8 studies
- New York17 studies
- North Carolina8 studies
- Ohio10 studies
- Oklahoma4 studies
- Oregon4 studies
- Pennsylvania10 studies
- South Carolina5 studies
- Tennessee12 studies
- Texas18 studies
- Virginia6 studies
- Washington8 studies
- Wisconsin6 studies
Recently updated studies
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Oct 2, 2026 · NCT00050752Distance-Based Exercise to Preserve Function and Prevent Disability
Recruiting
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07059884Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
RecruitingObservational studyHealthy volunteers welcome
4 Weeks · All sexes · Updated Oct 2, 2026 · NCT01109394[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Oct 2, 2026 · NCT06479811A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06234605Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT05287945Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Sep 30, 2026 · NCT00026884Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07011719Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Sep 28, 2026 · NCT00033137Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT04981119A Phase 1b Study of HC-7366, an Agonist of ISR With Immunotherapy in Kidney Cancer (SHARK)
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07401875NSAID Use After Robotic Partial Nephrectomy
RecruitingPhase 2
Ages 18 to 99 · All sexes · Updated Sep 24, 2026 · NCT05842044Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 18, 2026 · NCT06948552Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 18, 2026 · NCT07828704A Study of Theranostic Pair PD-32766D/T in Participants With Carbonic Anhydrase IX Positive Clear Cell Renal Cell Carcinoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07688187Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07227415Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
Recruiting
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06138067A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT05536141Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Aug 24, 2026 · NCT00001238A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT07123090A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT07195682Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT07300241Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT05433142A Study of a Side Effects and Resource Navigation Program for People With Cancer
Recruiting
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07646847Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)
RecruitingPhase 1/2
Ages 18 to 100 · All sexes · Updated Jul 29, 2026 · NCT05665361From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.